Beijing Bohui Innovation Biotechnology Group Co (SZSE:300318) EPS (Basic): ¥-0.12 (TTM As of Mar. 2026)


SZSE:300318 Beijing Bohui Innovation Biotechnology Group Co Ltd SZSE:300318
49 GF Score
Price ¥4.54
GF Value ¥5.36
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Beijing Bohui Innovation Biotechnology Group Co EPS (Basic)?

Beijing Bohui Innovation Biotechnology Group Co SZSE:300318 49 EPS (Basic) is ¥-0.12 as of Mar. 2026. GuruFocus rates SZSE:300318 with a GF Score™ of 49/100 and a GF Value™ of ¥5.36 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Beijing Bohui Innovation Biotechnology Group Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was ¥-0.01. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ¥-0.12.

Beijing Bohui Innovation Biotechnology Group Co's EPS (Diluted) for the three months ended in Mar. 2026 was ¥-0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ¥-0.12.

Beijing Bohui Innovation Biotechnology Group Co's EPS without NRI for the three months ended in Mar. 2026 was ¥-0.02. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was -0.02.

During the past 3 years, the average EPS without NRI Growth Rate was 11.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Beijing Bohui Innovation Biotechnology Group Co's highest 3-Year average EPS without NRI Growth Rate was 18.90% per year. The lowest was -102.90% per year. And the median was -10.90% per year.

Beijing Bohui Innovation Biotechnology Group Co  (SZSE:300318) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Beijing Bohui Innovation Biotechnology Group Co EPS (Basic) Related Terms

Beijing Bohui Innovation Biotechnology Group Co EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Beijing Bohui Innovation Biotechnology Group Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beijing Bohui Innovation Biotechnology Group Co EPS (Basic) Chart

Beijing Bohui Innovation Biotechnology Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.39 -0.10 -0.03 0.01 -0.11

Beijing Bohui Innovation Biotechnology Group Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.02 -0.02 -0.07 -0.01
SZSE:300318
49GF Score
Beijing Bohui Innovation Biotechnology Group Co Ltd SZSE:300318
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beijing Bohui Innovation Biotechnology Group Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Beijing Bohui Innovation Biotechnology Group Co's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-91.923-0)/817.095
=-0.11

Beijing Bohui Innovation Biotechnology Group Co's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-7.285-0)/818.562
=-0.01

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ¥-0.12 mean?
Beijing Bohui Innovation Biotechnology Group Co (SZSE:300318) has a EPS (Basic) of ¥-0.12 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Beijing Bohui Innovation Biotechnology Group Co and its competitors.
Is Beijing Bohui Innovation Biotechnology Group Co's EPS (Basic) too high?
Beijing Bohui Innovation Biotechnology Group Co's current EPS (Basic) is ¥-0.12. Overall, Beijing Bohui Innovation Biotechnology Group Co has a GF Score™ of 49/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Beijing Bohui Innovation Biotechnology Group Co's EPS (Basic) compare to VRTX and REGN?
Beijing Bohui Innovation Biotechnology Group Co's EPS (Basic) of ¥-0.12 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Beijing Bohui Innovation Biotechnology Group Co and its competitors. Beijing Bohui Innovation Biotechnology Group Co's current EPS (Basic) is ¥-0.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Bohui Innovation Biotechnology Group Co stock overvalued right now?
Based on GuruFocus' analysis, Beijing Bohui Innovation Biotechnology Group Co (SZSE:300318) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥5.36, compared to a current price of ¥4.54 — trading 15.3% below its estimated fair value. The current EPS (Basic) is ¥-0.12. Beijing Bohui Innovation Biotechnology Group Co's overall GF Score™ is 49/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Beijing Bohui Innovation Biotechnology Group Co (SZSE:300318), the current EPS (Basic) is ¥-0.12 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Beijing Bohui Innovation Biotechnology Group Co (SZSE:300318) Overvalued in 2026?

Based on GuruFocus' analysis, Beijing Bohui Innovation Biotechnology Group Co stock appears to be undervalued. The current stock price of ¥4.54 is trading 15.3% below its estimated GF Value™ of ¥5.36. GuruFocus considers Beijing Bohui Innovation Biotechnology Group Co to be Modestly Undervalued.

Key valuation signals for SZSE:300318:

  • EPS (Basic): ¥-0.12
  • GF Value™: ¥5.36 vs. price of ¥4.54 (15.3% below fair value)
  • GF Score™: 49/100 with 5 warning signs

No single metric tells the full story. See the SZSE:300318 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Beijing Bohui Innovation Biotechnology Group Co Business Description

Address Block G Jingxinyuan, NO.25 Jia Beiwucun Road, Haidian, Beijing, CHN, 100097
Beijing Bohui Innovation Biotechnology Group Co Ltd is a high-tech biomedical enterprise integrating R&D, production, sales, and after-sales service. The company focuses on the research and development, production, sales, and after-sales services of in vitro diagnostic products. The Company's business involved two segments: inspection and testing and biological products. The Biological segment generated the majority of its revenue which engaged in the research and development, production, and sales of blood products, the product range covers human blood albumin, human immunoglobulin, and human coagulation factor three categories of multiple varieties, basically covering the important varieties of blood products.
49GF Score

Get the complete analysis for SZSE:300318

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥4.54
Price
¥5.36
GF Value